Godrej Industries Ltd (GODREJIND)

Chemicals · Chemicals · NSE · Updated 1 September 2026

By StockFin Research Team • AI-Assisted Analysis • Source: BSE/NSE Filings

₹1,168.6 ↓ 4.86% (1Y)

🎯 Key Takeaways

Godrej Industries Ltd is navigating a strategic transition phase marked by leadership succession and capital restructuring amid mixed financial performance. The company has seen stable promoter holding but declining profitability and margin pressure in recent quarters, with revenue growth failing to translate into earnings expansion.
Revenue declined 29.2% QoQ to ₹5,448 in Q1FY27.
⚠️ Persistent margin pressure despite revenue growth, as seen in OPM decline from 13.3% to 8.1% over recent quarters, with management not providing clear

Market Cap

₹39,359

P/E Ratio

33.5

P/B Ratio

3.52

ROE

19.8%

ROCE

9.2%

Debt/Equity

4.57

Promoter

74.6%

✨ Ask AI About GODREJIND 📊 Interactive Charts

📖 The Story

Godrej Industries Ltd is navigating a strategic transition phase marked by leadership succession and capital restructuring amid mixed financial performance. The company has seen stable promoter holding but declining profitability and margin pressure in recent quarters, with revenue growth failing to translate into earnings expansion. Management is actively engaging shareholders on capital allocation and governance matters.

📰 What's Happening

In Q1 FY27, Godrej Industries reported consolidated revenue of ₹6,360 crores, up 11% YoY, but net profit declined 19% YoY to ₹284 crores due to margin pressure, despite strong volume growth in Chemicals and export segments. The Board approved unaudited financial results for Q1 FY27 on August 13, 2026, confirming compliance with SEBI norms and an unmodified limited review by KALYANIWALLA & MISTRY LLP. Shareholders approved the reappointment of Vishal Sharma as Whole Time Director and authorized a ₹1,500 crore unsecured NCD issuance, reflecting a strategic focus on capital raising and subsidiary investment. Pirojsha Godrej was re-designated as Executive Chairperson effective August 14, 2026, with a term until 2031, following shareholder approval via e-voting at the 38th AGM on August 13, 2026.

Source: Stock Announcements

📊 Quarterly Results (₹ Cr)

Metric	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	4,460	5,032	5,051	7,694	5,448
Operating Profit	283	13	418	1,026	441
OPM %	6.3%	0.3%	8.3%	13.3%	8.1%
Net Profit	725	493	353	841	523
EPS	₹10.37	₹7.20	₹6.07	₹13.19	₹8.44

The company's financial trajectory shows volatility in quarterly performance, with revenue peaking at ₹7,694 crores in Mar 2026 before declining to ₹5,448 crores in Jun 2026, while profitability remains inconsistent — OPM dropped from 13.3% to 8.1% over the same period. Despite year-on-year revenue growth in Q1 FY27, net profit fell sharply, indicating margin compression likely due to input costs or pricing pressures, even as operational performance improved in Chemicals and exports. The decline in operating cash flow to ₹-8,855 crores in Mar 2026 underscores liquidity strain, though financing activities helped offset it.

🔮 Management Outlook & What's Next

Management did not provide formal forward guidance in the latest financial results filing, but indicated plans to raise up to ₹1,500 crore via unsecured NCDs and invest ₹1,000 crore in Godrej Investment Limited, signaling intent to leverage debt for growth in subsidiaries. The reappointment of Vishal Sharma and succession of Pirojsha Godrej as Executive Chairperson reflect a focus on leadership continuity and governance stability. The Board emphasized compliance with SEBI and regulatory requirements, reinforcing transparency in disclosures and shareholder engagement through e-voting mechanisms.

Extracted from official company announcements. Not StockFin.ai's opinion.

🏦 Balance Sheet (₹ Cr)

Item	Mar 2025	Mar 2025	Mar 2026	Mar 2026
Equity Capital	34	34	34	34
Reserves	8,458	10,118	10,366	11,143
Borrowings	35,184	38,088	46,566	51,038
Total Liabilities	71,547	87,944	1.10 L Cr	1.26 L Cr
Fixed Assets	5,655	5,811	6,116	6,857
Investments	9,503	11,165	12,652	11,680
Total Assets	71,547	87,944	1.10 L Cr	1.26 L Cr

The balance sheet shows a significant rise in borrowings to ₹51,038 crores as of March 2026, up from ₹38,088 crores in March 2025, while equity and reserves increased modestly to ₹11,177 crores, indicating aggressive capital restructuring. Total assets grew to ₹1.26 lakh crores, suggesting expansion, but the rising debt-to-equity ratio of 4.57 raises concerns about financial leverage and interest burden amid soft profitability.

💰 Cash Flow Statement (₹ Cr)

Item	Mar 2026
Operating	-8,855
Investing	+202
Financing	+8,056
Net Cash Flow	-597

👥 Shareholding Pattern

Category	Q2FY26	Q3FY26	Q4FY26	Q1FY27
Promoters	71.3%	74.6%	74.6%	74.6%
FII	5.1%	4.9%	4.5%	4.6%
DII	2.8%	3.3%	3.5%	3.5%
Public	4.0%	3.7%	4.0%	3.9%
# Shareholders	82,219	81,889	84,014	84,502

Promoter holding remains stable at 74.64% over recent quarters, suggesting confidence from the Godrej family. However, FII allocation declined slightly to 4.57% in Q1FY27 from 5.12% in Q2FY26, while DII increased marginally to 3.47%, indicating mixed institutional interest. The growing number of shareholders (84,502 in Q1FY27) reflects retail participation, but the lack of significant FII accumulation may signal cautious sentiment despite governance improvements.

⚖️ Peer Comparison — Chemicals

Company	MCap (₹ Cr)	P/E	ROCE	ROE	D/E
PIDILITIND	1.66 L Cr	62.6	33.4%	24.7%	0.01
SRF	76,916	35.6	15.6%	15.4%	0.36
LINDEINDIA	55,474	101.5	17.5%	12.8%	0.00
FLUOROCHEM	52,441	85.7	9.6%	7.7%	0.34
NAVINFLUOR	43,655	55.2	22.2%	19.9%	0.31
GODREJIND	39,359	33.5	9.2%	19.8%	4.57
HSCL	33,953	42.2	20.7%	17.1%	0.16
DEEPAKNTR	24,047	30.7	15.3%	13.4%	0.26
AETHER	22,519	95.5	13.8%	10.6%	0.08
AARTIIND	19,602	36.9	9.2%	9.5%	0.68

🔗 Peer Stock Analyses

PIDILITIND SRF LINDEINDIA FLUOROCHEM NAVINFLUOR

⚠️ Risk Factors

1. Persistent margin pressure despite revenue growth, as seen in OPM decline from 13.3% to 8.1% over recent quarters, with management not providing clear mitigation plans. 2. Rising debt levels to fund NCD issuance and subsidiary investments could strain cash flows, especially with negative operating cash flow in recent periods. 3. Leadership transition involving Pirojsha Godrej’s re-designation is subject to shareholder approval, introducing governance uncertainty. 4. Agrovet segment performance remains mixed, with crop care declines offsetting dairy growth, posing execution risks in diversified operations.

📋 Recent Filings

🧠 Analyst's Read

Godrej Industries is in a pivotal phase of capital restructuring and leadership succession, with governance upgrades and shareholder-approved capital plans, but faces headwinds from margin compression and rising leverage. Investors should monitor the utilization of raised funds, trajectory of margin improvement, and clarity on growth drivers in Chemicals and subsidiary investments in the coming quarters.

Based on filing content and financial data. Not a recommendation.

Read the full analysis

Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.

2 free AI queries per day.

✨ Deep Dive with AI on GODREJIND

Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-09-01.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when GODREJIND files new disclosures

Track GODREJIND filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track GODREJIND — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd